HeidiJacobeMD
Dermatology • Dallas, TXAssistant Professor, Dermatology, University of Texas Southwestern Medical Center, Southwestern Medical School
Dr. Jacobe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Stop 9069
Dallas, TX 75390Phone+1 214-648-2985Fax+1 214-648-9292
Education & Training
University of Texas Southwestern Medical CenterResidency, Dermatology, 1997 - 2000
Baylor College of MedicineInternship, Internal Medicine, 1996 - 1997- Baylor College of MedicineClass of 1996
Certifications & Licensure
TX State Medical License 1998 - 2026
NC State Medical License 2000 - 2003- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea. Start of enrollment: 2004 Nov 01
- Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea Start of enrollment: 2012 May 01
- Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository Start of enrollment: 2007 May 01
Publications & Presentations
PubMed
- The skinny on skin: The role of skin-aware professionals in skin cancer surveillance.Kyra Diehl, Jacob Nelson, Olivia Haddadin, Elizabeth Stoos, Autumn Shafer
Journal of Cosmetic Dermatology. 2024-12-01 - Incidence and Prevalence of Morphea.Heejo Keum, Henry W Chen, Robert W Haley, Heidi T Jacobe
JAMA Dermatology. 2024-10-01 - Characterization of Endothelial Cell Subclusters in Localized Scleroderma Skin with Single-Cell RNA Sequencing Identifies NOTCH Signaling Pathway.Theresa Hutchins, Anwesha Sanyal, Deren Esencan, Robert Lafyatis, Heidi Jacobe
International Journal of Molecular Sciences. 2024-09-28
Journal Articles
- An Evaluation of the Performance of Current Morphea Subtype ClassificationsHeidi Jacobe, MD, JAMA Dermatology
- A Cross-Sectional Comparison of Magnetic Resonance Imaging Findings and Clinical Assessment in Patients with MorpheaShauna Goldman, Heidi T Jacobe, JAMA Dermatology
Other
- Morphea: Current ConceptsHeidi Jacobe, MD, ScienceDirect
https://www.doximity.com/articles/844e913b-eeea-47ac-9b2b-29be6753aa98
UpToDate, Wolters Kluwer Health - 2012-01-20
Press Mentions
Jeff Aronin Announces Matthew Gantz as CEO of Castle Creek BiosciencesMay 11th, 2021- Morphea Patients with Mucocutaneous Involvement: A Cross Sectional Study from the Morphea in Adults and Children (MAC) CohortNovember 26th, 2020
Role of Antibody Unclear in Scleroderma VariantAugust 10th, 2013
Professional Memberships
- Fellow
- Research Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
